For the development of new anticancer agents, 2,2':6',2 "-, 2,2':6'.3 "- an
d 2,2':6',4 " -terpyridine derivatives were designed and evaluated for thei
r topoisomerase I inhibitory activity and antitumor cytotoxicity. Structure
activity relationship studies indicated that 2,2':6',2 " -terpyridine deri
vatives were highly cytotoxic toward several human tumor cell lines, wherea
s 2,2':6',3 "- and 2,2':6',4 " -terpyridine derivatives were potent topoiso
merase I inhibitors. (C) 2001 Elsevier Science Ltd. All rights reserved.